ESTRELLA IMMUNOPHARMA INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$0.64
-12.27%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+34.5%
3 months
-8.7%
6 months
-60.8%
1 year
-74.9%
Year to date
-59.0%
52-week range
$0.31 – $3.05
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$27.8M
P/E
-2.8
P/B
-3.7
P/S
—
Revenue
$0
Net income
-$10.01M
Diluted EPS
-0.24
Gross margin
—
Net margin
—
Return on equity
121.70%
Total debt
$0
Cash
$146.67K
Free cash flow
-$9.38M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $0 | -$2.31M | — | — | -$1.78M |
| Mar 31, 2026 | $0 | -$2.29M | — | — | -$6.7M |
| Dec 31, 2025 | $0 | -$613.17K | — | — | -$177.49K |
| Sep 30, 2025 | $0 | -$4.8M | — | — | -$727.33K |
| Sep 30, 2025 | $0 | -$4.8M | — | — | -$727.33K |
| Jun 30, 2025 | $0 | -$5.54M | — | — | -$414.88K |
| Mar 31, 2025 | $0 | -$2.1M | — | — | -$465.98K |
| Dec 31, 2024 | $0 | -$1.05M | — | — | -$896.07K |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent ESLA news
All market newsNo ticker-linked stories are in the current archive.